or Try an Advanced Search...

    Technical Analysis for LRMR - Larimar Therapeutics, Inc.

    Grade Last Price % Change Price Change
    C 8.24 13.66% 0.99
    LRMR closed up 13.66 percent on Monday, July 1, 2024, on approximately normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Up
    Historical LRMR trend table...
    Date Alert Name Type % Chg
    Crossed Above 50 DMA Bullish 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Volume Surge Other 13.66%
    Wide Bands Range Expansion 13.66%
    Oversold Stochastic Weakness 13.66%
    Stochastic Buy Signal Bullish 12.11%
    Wide Bands Range Expansion 12.11%
    Oversold Stochastic Weakness 12.11%
    NR7 Range Contraction 17.38%
    Older End-of-Day Signals for LRMR ...

       Recent Intraday Alerts

    Alert Time
    Up 10% about 5 hours ago
    Up 1 ATR about 6 hours ago
    50 DMA Resistance about 7 hours ago
    Rose Above 50 DMA about 7 hours ago
    Rose Above Previous Day's High about 7 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    LRMR Chart by TradingView
    Basic chart:

    Profile

    Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases. The company's lead compound, CTI-1601, is being evaluated in a Phase 1 clinical program as a potential treatment for Friedreich's ataxia, a rare and progressive genetic disease. It also focuses on using its intracellular platform to design other fusion proteins to target additional rare diseases characterized by deficiencies in intracellular bioactive compounds. The company is headquartered in Bala Cynwyd, Pennsylvania.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Drug Discovery Rare Diseases Genetic Diseases Progressive Clinical Pharmacology Fusion Protein Ataxia Friedreich's Ataxia Trinucleotide Repeat Disorders

    Is LRMR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 31 Larimar: Stronger Buy Now More Than Ever After Partial Clinical Hold Completely Removed
    May 30 Larimar's Friedreich's ataxia asset nomlabofusp chosen for FDA accelerated program
    May 30 Larimar Therapeutics Selected by FDA to Participate in START Pilot Program for Nomlabofusp in Friedreich’s Ataxia
    May 21 Biggest stock movers today: ZIM, XPEV, PANW, GOTU, and more
    May 20 Larimar stock rallies 24% on FDA removal of partial clinical hold
    May 20 Larimar Therapeutics Announces FDA has Removed Partial Clinical Hold for Nomlabofusp Program in Friedreich’s Ataxia
    May 10 Companies Like Larimar Therapeutics (NASDAQ:LRMR) Are In A Position To Invest In Growth
    May 9 Larimar Therapeutics files for $300M mixed shelf offering
    May 9 Larimar Therapeutics GAAP EPS of -$0.27 misses by $0.04
    May 9 Larimar Therapeutics Reports First Quarter 2024 Operating and Financial Results
    See more LRMR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 13.68
    52 Week Low 2.18
    Average Volume 572,683
    200-Day Moving Average 6.15
    50-Day Moving Average 7.80
    20-Day Moving Average 8.55
    10-Day Moving Average 7.58
    Average True Range 0.71
    RSI (14) 52.15
    ADX 17.96
    +DI 28.83
    -DI 20.17
    Chandelier Exit (Long, 3 ATRs) 8.08
    Chandelier Exit (Short, 3 ATRs) 8.92
    Upper Bollinger Bands 10.62
    Lower Bollinger Band 6.49
    Percent B (%b) 0.42
    BandWidth 48.26
    MACD Line -0.18
    MACD Signal Line -0.03
    MACD Histogram -0.1492
    Fundamentals Value
    Market Cap 361.78 Million
    Num Shares 43.9 Million
    EPS -0.60
    Price-to-Earnings (P/E) Ratio -13.73
    Price-to-Sales 0.00
    Price-to-Book 3.68
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 10.15
    Resistance 3 (R3) 9.99 9.19 9.83
    Resistance 2 (R2) 9.19 8.71 9.27 9.72
    Resistance 1 (R1) 8.72 8.41 8.96 8.88 9.62
    Pivot Point 7.92 7.92 8.04 8.00 7.92
    Support 1 (S1) 7.45 7.44 7.69 7.61 6.86
    Support 2 (S2) 6.65 7.14 6.73 6.76
    Support 3 (S3) 6.18 6.65 6.65
    Support 4 (S4) 6.34